RELUGOLIX Pharmacologic Class Indexing
- Class set ID
- d4d6a8c0-ffc6-451d-bbec-c44f39bedf80
- Version
- 1
- Effective date
- 20210614
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use ORGOVYX safely and effectively. See full prescribing information for ORGOVYX. ORGOVYX (relugolix) tablets, for oral use Initial U.S. Approval: 2020 | Sumitomo Pharma America, Inc. | 20251010 | 12 |
| These highlights do not include all the information needed to use MYFEMBREE safely and effectively. See full prescribing information for MYFEMBREE. MYFEMBREE ® (relugolix, estradiol, and norethindrone acetate) tablets, for oral use Initial U.S. Approval: 2021 | Sumitomo Pharma America, Inc | Sumitomo Pharma Switzerland GmbH | 20250904 | 18 |